A detailed history of Driehaus Capital Management LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 362,212 shares of VCYT stock, worth $14.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
362,212
Holding current value
$14.3 Million
% of portfolio
0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $7.61 Million - $12.8 Million
362,212 New
362,212 $12.3 Million
Q4 2023

Feb 14, 2024

SELL
$19.72 - $28.68 $84,894 - $123,467
-4,305 Reduced 1.04%
408,930 $11.2 Million
Q3 2023

Nov 14, 2023

SELL
$22.33 - $29.92 $20,900 - $28,005
-936 Reduced 0.23%
413,235 $9.23 Million
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $310,354 - $399,640
14,807 Added 3.71%
414,171 $10.5 Million
Q1 2023

May 15, 2023

SELL
$20.58 - $27.89 $201,087 - $272,513
-9,771 Reduced 2.39%
399,364 $8.91 Million
Q4 2022

Feb 14, 2023

BUY
$15.31 - $29.94 $6.26 Million - $12.2 Million
409,135 New
409,135 $9.71 Million
Q2 2020

Aug 14, 2020

SELL
$19.49 - $28.11 $1.32 Million - $1.9 Million
-67,708 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$16.13 - $30.17 $5.75 Million - $10.8 Million
-356,606 Reduced 84.04%
67,708 $1.65 Million
Q4 2019

Feb 12, 2020

BUY
$20.78 - $29.99 $929,468 - $1.34 Million
44,729 Added 11.78%
424,314 $11.8 Million
Q3 2019

Nov 14, 2019

BUY
$23.87 - $30.93 $146,418 - $189,724
6,134 Added 1.64%
379,585 $9.11 Million
Q2 2019

Aug 14, 2019

BUY
$22.1 - $28.56 $5.57 Million - $7.19 Million
251,851 Added 207.11%
373,451 $10.6 Million
Q1 2019

May 15, 2019

SELL
$12.0 - $25.76 $707,280 - $1.52 Million
-58,940 Reduced 32.65%
121,600 $3.04 Million
Q4 2018

Feb 14, 2019

BUY
$9.15 - $14.85 $1.07 Million - $1.74 Million
117,240 Added 185.21%
180,540 $2.27 Million
Q3 2018

Nov 14, 2018

BUY
$9.55 - $12.64 $604,515 - $800,112
63,300 New
63,300 $605,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.83B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.